It was found, through in vitro observation, that reducing the expression of E-FABP through the knockdown or knockout of E-FABP can reduce prostate cancer proliferation and invasiveness, as well as inhibit metastasis and tumor growth in vivo [83]. Here, FABP5 is linked to prostate carcinoma.